Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)

BME:ROVI Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, BME:ROVI stock has a consensus rating of "Buy" and an average price target of €76.49. The average 1-year stock price forecast is 32.91% higher than the current stock price, while the lowest is €64.20 (+11.56%) and the highest is €90.00 (+56.39%).

Price Target: €76.49 (+32.91%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	€64.20	€76.49	€75.20	€90.00
Change	+11.56%	+32.91%	+30.67%	+56.39%

Analyst Ratings

The average analyst rating for BME:ROVI stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	5	5	4	4	4
Buy	2	2	2	2	2	1
Hold	2	2	2	3	3	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	9	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
James Vane Jefferies	Jefferies	Hold Maintains €83.50 → €64.20	Hold	Maintains	€83.50 → €64.20	+11.56%	May 14, 2026
Pablo de Renteria Kepler Capital	Kepler Capital	Buy Maintains €90.00 → €83.00	Buy	Maintains	€90.00 → €83.00	+44.22%	May 6, 2026

Financial Forecast

Revenue This Year

774.03M

Increased by 4.11%

from 743.48M

Revenue Next Year

913.11M

Increased by 17.97%

from 774.03M

EPS This Year

2.62

Decreased by -4.76%

from 2.75

EPS Next Year

3.57

Increased by 36.33%

from 2.62

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	648.68M	817.70M	829.51M	763.75M	743.48M	774.03M
Revenue Growth	54.46%	26.06%	1.44%	-7.93%	-2.65%	4.11%
Gross Profit	379.84M	512.43M	483.34M	467.71M	471.59M	519.06M
Gross Margin	58.56%	62.67%	58.27%	61.24%	63.43%	67.06%
Operating Income	180.15M	253.74M	219.47M	178.71M	173.14M	171.62M
Net Income	153.08M	199.67M	170.34M	136.88M	140.44M	132.98M
EPS	2.76	3.73	3.20	2.67	2.75	2.62
EPS Growth	150.36%	35.31%	-14.25%	-16.53%	2.73%	-4.76%
Forward PE	25.70	12.76	19.76	19.03	21.58	22.01
Dividend / Share	0.96	1.29	1.10	0.94	0.96	0.97
Dividend Growth	-	35.39%	-14.69%	-15.28%	2.60%	1.43%
Free Cash Flow	66.20M	135.92M	25.36M	44.85M	82.30M	94.50M
No. Analysts	-	-	-	-	-	8

Financial currency is EUR.

Revenue Forecast

Revenue	2026	2027	2028
High	791.0M
Avg	774.0M
Low	763.8M

Revenue Growth

Revenue Growth	2026	2027	2028
High	6.4%
Avg	4.1%
Low	2.7%

EPS Forecast

EPS	2026	2027	2028
High	2.83
Avg	2.62
Low	2.37

EPS Growth

EPS Growth	2026	2027	2028
High	3.1%
Avg	-4.8%
Low	-13.7%

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.